NasdaqCM - Delayed Quote USD

NRx Pharmaceuticals, Inc. (NRXPW)

Compare
0.1900
+0.0110
+(6.15%)
At close: January 29 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
20,476.0000
27,837.0000
44,335.0000
115,796.0000
51,387.0000
Operating Income
-20,476.0000
-27,837.0000
-44,335.0000
-115,796.0000
-51,387.0000
Net Non Operating Interest Income Expense
-196.0000
374.0000
249.0000
-18.0000
-56.0000
Other Income Expense
292.0000
-2,687.0000
4,332.0000
22,751.0000
-334.0000
Pretax Income
-20,380.0000
-30,150.0000
-39,754.0000
-93,063.0000
-51,777.0000
Net Income Common Stockholders
-20,389.0000
-30,159.0000
-39,754.0000
-348,885.0000
-51,777.0000
Diluted NI Available to Com Stockholders
-20,389.0000
-30,159.0000
-39,754.0000
-348,885.0000
-51,777.0000
Total Operating Income as Reported
-20,476.0000
-27,837.0000
-44,335.0000
-115,796.0000
-51,387.0000
Total Expenses
20,476.0000
27,837.0000
44,335.0000
115,796.0000
51,387.0000
Net Income from Continuing & Discontinued Operation
-20,380.0000
-30,150.0000
-39,754.0000
-93,063.0000
-51,777.0000
Normalized Income
-20,420.0000
-30,170.0000
-44,591.0000
-115,814.0000
-51,443.0000
Interest Income
114.0000
494.0000
249.0000
--
--
Interest Expense
310.0000
120.0000
--
18.0000
56.0000
Net Interest Income
-196.0000
374.0000
249.0000
-18.0000
-56.0000
EBIT
-20,070.0000
-30,030.0000
-39,754.0000
-93,045.0000
-51,721.0000
EBITDA
-20,065.0000
-30,025.0000
-39,750.0000
-93,043.0000
-51,719.0000
Reconciled Depreciation
5.0000
5.0000
4.0000
2.0000
2.0000
Net Income from Continuing Operation Net Minority Interest
-20,380.0000
-30,150.0000
-39,754.0000
-93,063.0000
-51,777.0000
Total Unusual Items Excluding Goodwill
40.0000
20.0000
4,837.0000
22,751.0000
-334.0000
Total Unusual Items
40.0000
20.0000
4,837.0000
22,751.0000
-334.0000
Normalized EBITDA
-20,105.0000
-30,045.0000
-44,587.0000
-115,794.0000
-51,385.0000
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PBMWW Psyence Biomedical Ltd.
0.0200
+25.00%
 
RVPHW Reviva Pharmaceuticals Holdings, Inc.
0.1499
-16.72%
 
CELUW Celularity Inc.
0.0667
+5.37%
 
IDD.F Innate Pharma S.A.
1.7220
-1.49%
 
ABPWW Abpro Holdings Inc
0.0500
0.00%
 
PSYBF PsyBio Therapeutics Corp.
0.0001
0.00%
 
LEXXW Lexaria Bioscience Corp.
0.4413
-8.06%
 
RLFTY Relief Therapeutics Holding SA
4.4000
0.00%
 
ICUCW SeaStar Medical Holding Corporation
0.0320
+13.07%
 
RCKTW Rocket Pharmaceuticals, Inc.
0.0783
+4.82%